{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:48:51Z","timestamp":1787640531063,"version":"build-2736575974"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101170","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:53:21Z","timestamp":1776441201000},"page":"101170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Patient selection for accelerated partial breast irradiation (APBI) after breast-conserving surgery: Updated evidence-based recommendations of the Groupe Europ\u00e9en de Curieth\u00e9rapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) Breast Cancer Working Group"],"prefix":"10.1016","volume":"59","author":[{"given":"Csaba","family":"Polg\u00e1r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gutierrez-Miguelez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Smanyk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Stankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-8703","authenticated-orcid":false,"given":"Irene","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"L\u00f6ssl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7659-7032","authenticated-orcid":false,"given":"Jose-Luis","family":"Guinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4672-6910","authenticated-orcid":false,"given":"Tibor","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Hannoun-Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vratislav","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101170_b0005","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ctro.2026.101170_b0010","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ctro.2026.101170_b0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0020","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0025","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101170_b0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semradonc.2004.10.004","article-title":"Brachytherapy for partial breast irradiation: the European experience","volume":"15","author":"Polg\u00e1r","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.semradonc.2004.10.005","article-title":"Breast brachytherapy: North American experience","volume":"15","author":"Vicini","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.semradonc.2004.10.008","article-title":"External-beam partial breast irradiation","volume":"15","author":"Formenti","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.semradonc.2004.10.009","article-title":"Intraoperative electrons","volume":"15","author":"Orecchia","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semradonc.2004.10.007","article-title":"TARgeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation","volume":"15","author":"Vaidya","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0055","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijrobp.2009.02.031","article-title":"Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)","volume":"74","author":"Smith","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.radonc.2010.01.014","volume":"94","author":"Polg\u00e1r","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.brachy.2013.02.001","article-title":"The American Brachytherapy Society consensus statement for accelerated partial breast irradiation","volume":"12","author":"Shah","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2026.101170_b0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement","volume":"7","author":"Correa","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brachy.2017.09.004","article-title":"The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation","volume":"17","author":"Shah","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2026.101170_b0080","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ctro.2026.101170_b0085","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ctro.2026.101170_b0090","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ijrobp.2020.11.006","article-title":"Breast-conserving surgery followed by partial or whole breast irradiation: twenty-year results of a phase 3 clinical study","volume":"109","author":"Polg\u00e1r","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0095","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1470-2045(25)00194-9","article-title":"Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial","volume":"26","author":"Kirby","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","article-title":"Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial","volume":"51","author":"Livi","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0105","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0110","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101170_b0115","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101170_b0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","volume":"387","author":"Strnad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101170_b0125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1470-2045(23)00018-9","article-title":"Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial","volume":"24","author":"Strnad","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0130","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s12094-021-02618-5","article-title":"Long-term results of a randomized partial irradiation trial compared to whole breast irradiation in the early stage and low-risk breast cancer patients after conservative surgery","volume":"23","author":"Li","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0135","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.22.00451","article-title":"Partial breast irradiation versus whole breast irradiation for early breast cancer patients in a randphase III trial: The Danish Breast Cancer Group partial breast irradiation trial","volume":"40","author":"Offersen","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0140","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1470-2045(21)00080-2","article-title":"Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial","volume":"22","author":"Orecchia","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.0249","article-title":"Effect of delayed targeted intraoperative radiotherapy vs whole-breast radiotherapy on local recurrence and survival: long-term results from the TARGIT-A randomized clinical trial in early breast cancer","volume":"6","author":"Vaidya","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0150","article-title":"Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial","volume":"370","author":"Vaidya","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ctro.2026.101170_b0155","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jamaoncol.2020.2716","article-title":"Targeted intraoperative radiotherapy for early breast cancer","volume":"6","author":"Bentzen","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000515386","article-title":"Long-term results of the TARGIT-A trial: More questions than answers","volume":"17","author":"Piroth","year":"2022","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.ctro.2026.101170_b0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2021.12.161","article-title":"An estimate of local failure in the TARGIT-A trial of pre-pathology intraoperative radiation therapy for early breast cancer","volume":"115","author":"Matthew","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.radonc.2011.03.011","article-title":"Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis","volume":"100","author":"Shah","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12094-021-02664-z","article-title":"Comparison between accelerated partial breast irradiation with multicatheter interstitial brachytherapy and whole breast irradiation, in clinical practice","volume":"24","author":"Gardu\u00f1o-S\u00e1nchez","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1748-717X-7-53","article-title":"Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation","volume":"7","author":"Ferraro","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0185","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijrobp.2023.01.049","article-title":"Whole breast irradiation versus intraoperative electron radiation therapy for breast conserving therapy: a large mature single institution matched-pair evaluation of true local relapse, progression free survival, and overall survival","volume":"116","author":"De Rose","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0190","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1245\/s10434-017-5953-9","article-title":"A single institution retrospective comparison study of locoregional recurrence after accelerated partial breast irradiation using external beam fractionation compared with whole breast irradiation with 8 years of follow-up","volume":"24","author":"Shah","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0195","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/COC.0000000000000082","article-title":"Brachytherapy-based accelerated partial breast irradiation provides equivalent 10-year outcomes to whole breast irradiation: a matched-pair analysis","volume":"39","author":"Wobb","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13058-024-01936-0","article-title":"Intraoperative radiotherapy versus whole breast radiotherapy in early-stage breast cancer: a retrospective outcome analysis based on ASTRO guidelines on PBI","volume":"26","author":"Gao","year":"2024","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ctro.2026.101170_b0205","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijrobp.2022.03.010","article-title":"Accelerated partial breast irradiation using external beam or intraoperative electron radiation therapy: 5-year oncological outcomes of a prospective cohort study","volume":"113","author":"Jacobs","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0210","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ijrobp.2010.04.032","article-title":"Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence","volume":"80","author":"Ott","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0215","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1245\/s10434-012-2694-7","article-title":"Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI","volume":"20","author":"Vicini","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0220","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/COC.0000000000000334","article-title":"Outcomes of node-positive breast cancer patients treated with accelerated partial breast irradiation via multicatheter interstitial brachytherapy: the pooled registry of multicatheter interstitial sites (PROMIS) experience","volume":"41","author":"Kamrava","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0225","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/1097-0142(197301)31:1<110::AID-CNCR2820310115>3.0.CO;2-V","article-title":"Infiltrating lobular carcinoma of the breast","volume":"31","author":"Ashikar","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0230","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/bjs.1800821023","article-title":"Lobular carcinoma of the breast can be managed by breast conserving therapy","volume":"82","author":"Holland","year":"1995","journal-title":"Br J Surg"},{"key":"10.1016\/j.ctro.2026.101170_b0235","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1002\/cncr.21921","article-title":"Selecting patients for breast-conserving therapy. The importance of lobular histology","volume":"106","author":"Morrow","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8","article-title":"Infiltrating lobular carcinoma of the breast: clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns","volume":"77","author":"Sastre-Garau","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0245","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B","article-title":"Infiltrating lobular carcinoma: is it different from infiltrating duct carcinoma?","volume":"73","author":"Silverstein","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1006384407690","article-title":"The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy","volume":"59","author":"Peiro","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctro.2026.101170_b0255","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/1097-0142(19890715)64:2<448::AID-CNCR2820640218>3.0.CO;2-7","article-title":"Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy","volume":"64","author":"Schnitt","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0260","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0360-3016(92)90898-R","article-title":"Outcome of conservative therapy for invasive breast cancer by histologic subtype","volume":"23","author":"Weiss","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0265","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brachy.2020.08.012","article-title":"Accelerated partial breast irradiation in the elderly: 8-year oncological outcomes and prognostic factors","volume":"20","author":"Sumodhee","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2026.101170_b0270","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s11845-020-02237-z","article-title":"A prospective feasibility study of MammoSite accelerated partial breast irradiation for early breast cancer","volume":"189","author":"Geary","year":"2020","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.ctro.2026.101170_b0275","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1748-717X-9-115","article-title":"Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy","volume":"9","author":"Genebes","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0280","doi-asserted-by":"crossref","first-page":"e1931","DOI":"10.1002\/onco.13980","article-title":"Increased risk for ipsilateral breast tumor recurrence in invasive lobular carcinoma after accelerated partial breast irradiation brachytherapy","volume":"26","author":"Mills","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.ctro.2026.101170_b0285","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ijrobp.2024.10.024","article-title":"Accelerated partial breast irradiation for early-stage invasive lobular carcinoma","volume":"121","author":"Braunstein","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0290","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1245\/s10434-012-2489-x","article-title":"Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite Registry trial","volume":"19","author":"Beitsch","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0295","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1245\/s10434-021-11295-1","article-title":"Recurrence and survival rates for 1400 early breast tumors treated with intraoperative radiation therapy (IORT)","volume":"29","author":"Silverstein","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0300","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1748-717X-7-17","article-title":"Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-up","volume":"7","author":"Shaikh","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0305","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2010.05.011","article-title":"Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features","volume":"81","author":"McHaffie","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0310","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.prro.2021.08.009","article-title":"Five-fraction prone accelerated partial breast irradiation: Long-term oncologic, dosimetric, and cosmetic outcome","volume":"12","author":"Shah","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0315","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.radonc.2017.07.015","article-title":"Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study","volume":"124","author":"Aristei","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0320","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2022.09.062","article-title":"A meta-analysis of trials of partial breast irradiation","volume":"115","author":"Goldberg","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0325","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0360-3016(85)90372-4","article-title":"Analysis of local regional relapses in patients with early breast cancers treated by excision and radiotherapy. Experience of the institute gustave roussy","volume":"11","author":"Clarke","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0330","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF03032380","article-title":"The role of boost irradiation in the conservative treatment of stage I-II breast cancer","volume":"7","author":"Polg\u00e1r","year":"2001","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.ctro.2026.101170_b0335","article-title":"Electron and brachytherapy boost in the conservative treatment of stage I-II breast cancer: 5-year results of the randomized Budapest boost trial","volume":"64","author":"Polg\u00e1r","year":"2002","journal-title":"[Abstract] Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(87)80016-6","article-title":"Tumor excision and radiotherapy as primary treatment of breast cancer: analysis of patient and treatment parameters and local control","volume":"8","author":"Van Limbergen","year":"1987","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0345","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/S0959-8049(03)00605-1","article-title":"Size of invasive breast cancer and risk of local recurrence after breast-conservation therapy","volume":"39","author":"Asgeirsson","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0350","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/1097-0142(19850901)56:5<979::AID-CNCR2820560502>3.0.CO;2-N","article-title":"Histologic multifocality of Tis, T1-2 breast carcinomas: implication for clinical trials of breast-conserving surgery","volume":"56","author":"Holland","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0355","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ijrobp.2005.06.028","article-title":"Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy","volume":"64","author":"Wazer","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0360","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0360-3016(00)01541-8","article-title":"Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer","volume":"50","author":"Wazer","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0365","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00000658-199307000-00005","article-title":"Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy","volume":"218","author":"Anscher","year":"1993","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctro.2026.101170_b0370","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2212::AID-CNCR16>3.0.CO;2-X","article-title":"The number of positive margins influences the outcome of women treated breast preservation for early stage breast carcinoma","volume":"82","author":"DiBiase","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0375","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/1097-0142(19940915)74:6<1746::AID-CNCR2820740617>3.0.CO;2-Y","article-title":"The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy","volume":"74","author":"Schnitt","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0380","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamaoncol.2016.3031","article-title":"Prognostiv factors for local control in breast cancer after lomg-term follow-up in the EORTC boost vs no boost trial: a randomized clinical trial","volume":"3","author":"Vrieling","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0385","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2013.11.012","article-title":"Society of surgical oncology-American society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer","volume":"88","author":"Moran","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0390","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.prro.2016.06.011","article-title":"Society of surgical oncology-American society for radiation oncology-american society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ","volume":"6","author":"Morrow","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0395","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1245\/s10434-014-3480-5","article-title":"The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis","volume":"21","author":"Houssami","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0400","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1245\/s10434-020-08878-9","article-title":"The diminishing impact of margin definitions and width on local recurrence rates following breast-conserving therapy for early-stage invasive cancer: a meta-analysis","volume":"27","author":"Shah","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0405","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ijrobp.2018.03.005","article-title":"Close margins less than 2 mm are not associated with higher risks of 10-year local recurrence and breast cancer mortality compared with negative margins in women treated with breast-conserving therapy","volume":"101","author":"Tyler","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0410","article-title":"Impact of resection margin width on local recurrence following breast-conserving surgery and whole breast radiotherapy for pure ductal carcinoma in situ: a systematic review and meta-analysis","volume":"4","author":"Ezzat","year":"2025","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0415","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ijrobp.2007.12.056","article-title":"A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17","volume":"72","author":"Arthur","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0420","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9610(00)00454-2","article-title":"Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer","volume":"180","author":"King","year":"2000","journal-title":"Am J Surg"},{"key":"10.1016\/j.ctro.2026.101170_b0425","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ijrobp.2007.12.005","article-title":"Clinical outcome analysis in \u201dhigh-risk\u201d versus \u201dlow-risk\u201d patients eligible for national surgical adjuvant breast and bowel B-39\/radiation therapy oncology group 0413 trial: five-year results","volume":"70","author":"Patel","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0430","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1200\/JCO.1990.8.1.113","article-title":"The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast","volume":"8","author":"Holland","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0435","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archsurg.1990.01410180097016","article-title":"Predictors of local recurrence following conservative breast surgery and radiation therapy","volume":"125","author":"Eberlein","year":"1990","journal-title":"Arch Surg"},{"key":"10.1016\/j.ctro.2026.101170_b0440","first-page":"181","article-title":"The impact of radiotherapy on the incidence and time of occurrence of local recurrence in early-stage breast cancer after breast conserving therapy","volume":"47","author":"Fodor","year":"2000","journal-title":"Neoplasma"},{"key":"10.1016\/j.ctro.2026.101170_b0445","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0360-3016(97)00325-8","article-title":"Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy","volume":"39","author":"Wazer","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0450","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0360-3016(91)90771-U","article-title":"Ten year results of conservative surgery and irradiation for stage I and II breast cancer","volume":"21","author":"Fowble","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0455","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1148\/radiology.183.1.1549685","article-title":"Breast cancer with extensive intraductal component: treatment with immediate interstitial boost irradiation","volume":"183","author":"Krishnan","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.ctro.2026.101170_b0460","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjsurg.2008.09.016","article-title":"Four-year clinical update from the American society of breast surgeons mammosite brachytherapy trial","volume":"198","author":"Nelson","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.ctro.2026.101170_b0465","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1245\/s10434-013-3015-5","article-title":"Locoregional recurrence following accelerated partial breast irradiation for early-stage invasive breast cancer: significance of estrogen receptor status and other pathological variables","volume":"20","author":"Cannon","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0470","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.brachy.2022.07.004","article-title":"Partial breast irradiation: An updated consensus statement from the American brachytherapy society","volume":"21","author":"Anderson","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2026.101170_b0475","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.prro.2023.11.001","article-title":"Partial Breast Irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an ASTRO clinical practice guideline","volume":"14","author":"Shaitelman","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0480","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.brachy.2009.08.011","article-title":"Preliminary results with accelerated partial breast irradiation in high-risk breast cancer patients","volume":"9","author":"Wilder","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2026.101170_b0485","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1002\/cncr.25383","volume":"116","author":"Shaitelman","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0490","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.14694\/EdBook_AM.2014.34.e32","article-title":"Should triple-negative breast cancer (TNBC) subtype affect local-regional therapy decision making?","author":"Moran","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ctro.2026.101170_b0495","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.brachy.2017.10.009","article-title":"Outcomes by molecular subtype after accelerated partial breast irradiation using single-entry catheters","volume":"17","author":"Saini","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2026.101170_b0500","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijrobp.2023.08.062","article-title":"Accelerated partial breast irradiation for HER2-positive early-stage breast cancer","volume":"118","author":"O'Brien","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0505","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1200\/JCO.20.03398","article-title":"Adjuvant trastuzumab emtansine versus paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT): a randomized clinical trial","volume":"39","author":"Tolaney","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0510","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1470-2045(23)00051-7","article-title":"Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial","volume":"24","author":"Tolaney","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0515","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.617439","article-title":"Outcomes after accelerated partial breast irradiation in women with triple negative subtype and other \u201chigh risk\u201d variables categorized as cautionary in the ASTRO guidelines","volume":"11","author":"Goulding","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0520","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12885-022-09193-0","article-title":"Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis","volume":"22","author":"Zhong","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2026.101170_b0525","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.breast.2019.02.004","article-title":"Recurrence in early breast cancer: analysis of data from 3,765 Australian women treated between 1997 and 2015","volume":"44","author":"Stuart-Harris","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.ctro.2026.101170_b0530","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ijrobp.2024.04.073","article-title":"The presence of extensive lymphovascular invasion is associated with higher risks of local-regional recurrence compared with usual lymphovascular invasion in curatively treated breast cancer patients","volume":"120","author":"Koleoso","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0535","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1524-4741.2012.01271.x","article-title":"Lymphatic space invasion is not an independent predictor of outcomes in early stage breast cancer treated by breast-conserving surgery and radiation","volume":"18","author":"Freedman","year":"2012","journal-title":"Breast J"},{"key":"10.1016\/j.ctro.2026.101170_b0540","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.brachy.2017.09.009","article-title":"Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: results of a prospective single-institutional registry","volume":"17","author":"Gabani","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2026.101170_b0545","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13058-022-01582-4","article-title":"Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry","volume":"24","author":"Philippson","year":"2022","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ctro.2026.101170_b0550","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.clon.2005.07.018","article-title":"A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer","volume":"17","author":"Dodwell","year":"2005","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0555","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0167-8140(96)01747-1","article-title":"Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results of a randomised trial","volume":"39","author":"Magee","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0560","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0360-3016(03)00816-2","article-title":"Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years\u2019 minimum follow-up","volume":"57","author":"Perera","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0565","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2008.02.022","article-title":"Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1-T2 breast cancer: first long time results from a clinical study","volume":"90","author":"Johansson","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0570","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2006.08.028","article-title":"Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial","volume":"82","author":"Ott","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0575","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1016\/j.ijrobp.2011.05.066","article-title":"Impact of lymph node status on clinical outcomes after accelerated partial breast irradiation","volume":"82","author":"Shah","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101170_b0580","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","article-title":"Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial","volume":"9","author":"Gentilini","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0585","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","article-title":"Axillary surgery in breast cancer - primary results of the INSEMA trial","volume":"392","author":"Reimer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2026.101170_b0590","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMe2414899","article-title":"Sentinel-lymph node biopsy in early-stage breast cancer \u2013 is it obsolete?","volume":"392","author":"Morrow","year":"2025","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ctro.2026.101170_b0595","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.radonc.2018.04.009","article-title":"ESTRO-ACROP guideline: interstitial multi-catheter breast brachytherapy as accelerated partial breast irradiation alone or as boost - GEC-ESTRO breast cancer working group practical recommendations","volume":"128","author":"Strnad","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0600","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.radonc.2015.06.010","article-title":"Recommendations from GEC ESTRO breast cancer working group (I): target definition and target delineation for accelerated or boost partial breast irradiation using multicatheter interstitial brachytherapy after breast conserving closed cavity surgery","volume":"115","author":"Strnad","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101170_b0605","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.radonc.2015.12.006","article-title":"Recommendations from GEC ESTRO Breast Cancer Working Group (II): target definition and target delineation for accelerated or boost partial breast irradiation using multicatheter interstitial brachytherapy after breast conserving open cavity surgery","volume":"118","author":"Major","year":"2016","journal-title":"Radiother Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:41:19Z","timestamp":1783395679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":121,"alternative-id":["S2405630826000650"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101170","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient selection for accelerated partial breast irradiation (APBI) after breast-conserving surgery: Updated evidence-based recommendations of the Groupe Europ\u00e9en de Curieth\u00e9rapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) Breast Cancer Working Group","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101170"}}